Elevated concentrations of circulating anti-MAA antibodies targeting modified fibrinogen, albumin, vimentin, and collagen have been reported in RA and associated with other fibrotic extra-articular manifestations, including RA interstitial lung disease [27,29,30]. The gene discussed is VIM; the disease is rheumatoid arthritis.